(1)
Ravasio, R.; Antonelli, S.; Rogai, V.; Fakhouri, W.; Capron, J. P.; Losi, S. Mean Cost Per Number Needed to Treat of Baricitinib Versus Adalimumab in the Treatment of Rheumatoid Arthritis in Italy. Grhta 2018, 5.